- Harrow Health (NASDAQ:HROW) is scheduled to announce Q4 earnings results on Monday, March 17th, after market close.
- The consensus EPS Estimate is $0.04 (+120.0% Y/Y) and the consensus Revenue Estimate is $58.41M (+60.6% Y/Y).
- Over the last 2 years, HROW
